Seegene Executive and Leadership Team

Daehoon Lee, the Chief Executive Officer at Seegene, directs the company's overall strategic vision and operational execution. Overseeing all business units, Daehoon Lee ensures alignment with Seegene's mission to pioneer multiplex molecular diagnostics. This leadership role involves driving market expansion and fostering innovation within the research and development teams. By optimizing resource allocation and guiding corporate strategy, Daehoon Lee directly impacts Seegene's growth trajectory. Ultimately, Daehoon Lee secures the company's competitive edge in the global diagnostics market, focusing on scalable solutions for clinical molecular diagnostics.

Jong-Yoon Chun, the Founder & Chief Executive Officer at Seegene, spearheads the company's foundational principles and long-term strategic direction. As the originator of Seegene's core technologies, Jong-Yoon Chun guides the enterprise in its pursuit of groundbreaking multiplex molecular diagnostics. This executive position involves championing the company's research and development initiatives, ensuring a continuous pipeline of advanced M-MoDx solutions. By maintaining a focus on technological superiority and market leadership, Jong-Yoon Chun cultivates an environment of scientific excellence. The Founder & Chief Executive Officer's influence extends to shaping Seegene's global presence and its commitment to addressing critical healthcare needs through molecular innovation.

James Yantzi, the President at Seegene, manages the company's global operational framework and drives business development initiatives. Overseeing day-to-day operations, James Yantzi ensures seamless execution of Seegene's strategic objectives across all regions. This executive function involves optimizing supply chain logistics, enhancing customer engagement, and expanding market penetration for Seegene's multiplex molecular diagnostics. By fostering strong relationships with partners and stakeholders, James Yantzi facilitates the company's growth and reinforces its position in the international market. The President's leadership is vital for translating technological advancements into accessible and impactful clinical solutions worldwide.

Min-Cheol Lee, the Chief Technology Officer at Seegene, architects the company's technological roadmap and oversees all research and development efforts. Min-Cheol Lee drives the advancement of Seegene's proprietary multiplex molecular technologies, ensuring the company remains at the forefront of molecular diagnostics innovation. This critical role involves managing the engineering and scientific teams responsible for developing and refining M-MoDx platforms. By fostering a culture of scientific inquiry and rigorous testing, Min-Cheol Lee ensures the reliability and efficacy of Seegene's diagnostic solutions. The Chief Technology Officer's strategic oversight is essential for translating complex scientific discoveries into market-ready products that address global health challenges.